Your Article Summary
See Latest ArticlesPaclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
New England Journal of Medicine, 12/27/07
Miller K et al. - In a trial to compare the efficacy and safety of paclitaxel with paclitaxel plus bevacizumab as initial treatment for metastatic breast cancer, it was found that paclitaxel plus bevacizumab prolongs progression-free survival, but not overall survival, as compared with paclitaxel alone
Methods- Patients were assigned to receive 90 mg of paclitaxel per square meter of body-surface area on days 1, 8, and 15 every 4 weeks, either alone or with 10 mg of bevacizumab per kilogram of body weight on days 1 and 15
- The primary end point was progression-free survival; overall survival was a secondary end point
- 722 patients were enrolled
- Paclitaxel plus bevacizumab significantly prolonged progression-free survival and increased the objective response rate
- Overall survival rate, however, was similar in the two groups
- Grade 3 or 4 hypertension, proteinuria, headache, and cerebrovascular ischemia were more frequent in patients receiving paclitaxel plus bevacizumab
- Infection was more common in patients receiving paclitaxel plus bevacizumab, but febrile neutropenia was uncommon
Related Articles
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09
Relevance Score: 74%
Advanced Breast Cancer and Breast Cancer Mortality in Randomized Controlled Trials on Mammography Screening
Journal of Clinical Oncology, 11/09/09
Relevance Score: 72%
Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients
Breast Cancer Research and Treatment, 10/27/09
Relevance Score: 72%
Underweight and breast cancer recurrence and death: A report from the Korean breast cancer society
Journal of Clinical Oncology, 10/08/09
Relevance Score: 72%
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study
Cancer Epidemiology, Biomarkers & Prevention, 10/01/09
Relevance Score: 72%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Method of Detection of Breast Cancer in Low-Income Women
Journal of Women's Health, 12/10/09
Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial
The Lancet - Early Online Publication, 12/10/09
Is excisional biopsy indicated for patients with lobular neoplasia diagnosed on percutaneous core needle biopsy of the breast
The American Journal of Surgery, 12/10/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
A Ruptured Ectopic Pregnancy Without Sustained Bleeding After Administration of Methotrexate
Journal of Gynecologic Surgery, 12/10/09
Autoimmune Thyroid Disease in Pregnancy: A Review
Journal of Women's Health, 12/10/09
Changes in the Vaginal Microenvironment with Metronidazole Treatment for Bacterial Vaginosis in Early Pregnancy
Journal of Women's Health, 12/10/09